Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00347763 · ClinicalTrials.gov registry record · Phase 4

Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania

A Phase 4 study of Trachoma, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 4
Development phase
350
Enrollment target
1
Study location

NCT00347763 is a Phase 4 study of Trachoma that has completed, run by Johns Hopkins University. The registered enrollment target is 350 participants, below the 80,478-participant average among 4 other Trachoma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00347763, a Phase 4 study of Trachoma, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 4
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

The purpose of this community-based randomized trial was to determine, in trachoma hyper-endemic communities of Tanzania, the added value of intensive spraying to control flies on the fly population and on trachoma and ocular chlamydia infection at 6 months and one year after mass antibiotic treatment.

Conditions Studied

Interventions

  • PROCEDURE 10% permethrin in water applied as low volume spray

Study Locations (1)

Maryland

  • Johns Hopkins University/ Kongwa Trachoma Project - Baltimore

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2000-06
Est. Completion 2002-10
Phase Phase 4

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT00347763

The ClinicalTrials.gov registry entry for NCT00347763 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80,478-participant average among 4 other Trachoma trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Trachoma appearing as the primary indexed condition, and to 1 intervention - of which 10% permethrin in water applied as low volume spray is the first listed.

NCT00347763 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00347763 about?

NCT00347763 is a clinical study titled "Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania". The purpose of this community-based randomized trial was to determine, in trachoma hyper-endemic communities of Tanzania, the added value of intensive spraying to control flies on the fly population and on trachoma and ocular chlamydia infection at 6 months and one year after mass antibiotic treatme...

What is the current status of trial NCT00347763?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2000-06. Estimated completion is 2002-10.

What conditions does trial NCT00347763 study?

This clinical trial studies the following conditions: Trachoma.

What interventions are being tested in trial NCT00347763?

The interventions under investigation include: 10% permethrin in water applied as low volume spray (PROCEDURE).

Who is sponsoring clinical trial NCT00347763?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00347763 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trachoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.